Durable complete response after combined treatment with tumor-infiltrating lymphocytes and oncolytic adenovirus (TILT-123) in a patient with metastatic mucosal melanoma.
Monberg TJ, Kudling T, Albieri B, Pakola S, Ellebaek E, Donia M, Eefsen RL, von Buchwald C, Kistler C, Santos JM, Clubb J, Haybout L, Westergaard MCW, Quixabeira DCA, Jirovec E, Havunen R, Sorsa S, Cervera-Carrascon V, Hemminki A, Svane IM.
Monberg TJ, et al. Among authors: santos jm.
Immunooncol Technol. 2024 Aug 12;24:100726. doi: 10.1016/j.iotech.2024.100726. eCollection 2024 Dec.
Immunooncol Technol. 2024.
PMID: 39801682
Free PMC article.